BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10576593)

  • 1. Comparison of A68 levels in Alzheimer diseased and non-Alzheimer's diseased brain by two ALZ50 based methods.
    Miller BE
    Life Sci; 1999; 65(21):2215-22. PubMed ID: 10576593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-induced loss of Alz-50 immunoreactivity with the A68 proteins from Alzheimer brain is mediated by ubiquitin.
    Vincent IJ; Davies P
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4840-4. PubMed ID: 2162059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities.
    Brion JP; Hanger DP; Couck AM; Anderton BH
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):831-6. PubMed ID: 1953678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation characteristics of the A68 protein in Alzheimer's disease.
    Vincent IJ; Davies P
    Brain Res; 1990 Oct; 531(1-2):127-35. PubMed ID: 2126970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments.
    Crowe A; Ksiezak-Reding H; Liu WK; Dickson DW; Yen SH
    Am J Pathol; 1991 Dec; 139(6):1463-70. PubMed ID: 1721492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible phosphorylation of tau to form A68 in heat-shocked neuronal PC12 cells.
    Wallace W; Johnson G; Sugar J; Merril CR; Refolo LM
    Brain Res Mol Brain Res; 1993 Jul; 19(1-2):149-55. PubMed ID: 8361338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer-related neuronal protein A68: specificity and distribution.
    Wolozin B; Davies P
    Ann Neurol; 1987 Oct; 22(4):521-6. PubMed ID: 3435070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer disease proteins (A68) share epitopes with tau but show distinct biochemical properties.
    Ksiezak-Reding H; Binder LI; Yen SH
    J Neurosci Res; 1990 Mar; 25(3):420-30. PubMed ID: 1691309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.
    Lee VM; Balin BJ; Otvos L; Trojanowski JQ
    Science; 1991 Feb; 251(4994):675-8. PubMed ID: 1899488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of Alzheimer's disease-associated protein (ADAP) in 10 human brains.
    Miller BE; Whetsell WO; Chong JK; Ghanbari HA
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):303-7. PubMed ID: 1498582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer disease A68 proteins injected into rat brain induce codeposits of beta-amyloid, ubiquitin, and alpha 1-antichymotrypsin.
    Shin RW; Bramblett GT; Lee VM; Trojanowski JQ
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6825-8. PubMed ID: 8393578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.
    Takeda A; Smith MA; Avilá J; Nunomura A; Siedlak SL; Zhu X; Perry G; Sayre LM
    J Neurochem; 2000 Sep; 75(3):1234-41. PubMed ID: 10936206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.
    Hanger DP; Brion JP; Gallo JM; Cairns NJ; Luthert PJ; Anderton BH
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):99-104. PubMed ID: 1826835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of protein kinase C in inducing Alzheimer's A68 protein expression in the culture of human neuroblastoma cells.
    Zhang L
    Neurosci Lett; 1994 Nov; 181(1-2):95-7. PubMed ID: 7898780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neuronal antigen in the brains of Alzheimer patients.
    Wolozin BL; Pruchnicki A; Dickson DW; Davies P
    Science; 1986 May; 232(4750):648-50. PubMed ID: 3083509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-shocked neuronal PC12 cells reveal Alzheimer's disease--associated alterations in amyloid precursor protein and tau.
    Johnson G; Refolo LM; Wallace W
    Ann N Y Acad Sci; 1993 Sep; 695():194-7. PubMed ID: 8239282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A different view of A68 and amyloid.
    Davies P
    Neurobiol Aging; 1989; 10(5):408-9; discussion 412-4. PubMed ID: 2682319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamina-selective A68 immunoreactivity in primary visual cortex of Alzheimer's disease patients.
    Beach TG; Walker R; McGeer EG
    Brain Res; 1989 Oct; 501(1):171-4. PubMed ID: 2804692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.
    Piñero DJ; Hu J; Connor JR
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):761-76. PubMed ID: 10875438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.